Healthcare IT News January 9, 2018
Biotechnology was by far the most invested-in group, with $13.8 billion in investments, and Oncology specialty is the biggest draw, AngelMD report shows.
Investment and networking platform AngelMD’s new report shows healthcare technology investment surged ahead in 2017, with California leading the charge and the biotechnology group more than doubling the amount of investment reported.
AngelMD looked at more than 2,500 Securities and Exchange Commission filings to get a clearer picture of where private healthcare investors were spending their money in 2017. Privately held companies that raised funds must file with the SEC to declare exempt offering of securities — making the filings a good barometer for where investments are being made.
[Also: Microsoft vs. Google: Hot start to 2018...